Compare Neurocrine Biosciences Inc (NBIX) vs Teucrium Wheat Fund (WEAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Teucrium Wheat Fund — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Teucrium Wheat Fund trades at $25.21. Which is the better fit depends on your goals.
| NBIX | WEAT | |
|---|---|---|
Market Cap | $17.40B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $180.55 | $25.49 |
52-Week Low | $123.10 | $19.88 |
Enterprise Value | $16.49B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Teucrium Wheat Fund
WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.
Read more on WEAT →
